GR76863B - - Google Patents

Info

Publication number
GR76863B
GR76863B GR69093A GR820169093A GR76863B GR 76863 B GR76863 B GR 76863B GR 69093 A GR69093 A GR 69093A GR 820169093 A GR820169093 A GR 820169093A GR 76863 B GR76863 B GR 76863B
Authority
GR
Greece
Application number
GR69093A
Other languages
Greek (el)
Inventor
Edward Lunt
Malcolm Francis Graham S Stone
Kenneth Robert Harr Wooldridge
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of GR76863B publication Critical patent/GR76863B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GR69093A 1981-08-24 1982-08-23 GR76863B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24

Publications (1)

Publication Number Publication Date
GR76863B true GR76863B (enExample) 1984-09-04

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
GR69093A GR76863B (enExample) 1981-08-24 1982-08-23

Country Status (29)

Country Link
JP (1) JPS5843975A (enExample)
KR (1) KR890000094B1 (enExample)
AT (1) AT380256B (enExample)
AU (1) AU571430B2 (enExample)
BE (1) BE894175A (enExample)
CA (1) CA1197247A (enExample)
CH (1) CH655114A5 (enExample)
DE (2) DE19975037I2 (enExample)
DK (1) DK161147C (enExample)
ES (1) ES515176A0 (enExample)
FI (1) FI73434C (enExample)
FR (1) FR2511679A1 (enExample)
GB (1) GB2104522B (enExample)
GE (1) GEP19960641B (enExample)
GR (1) GR76863B (enExample)
HU (1) HU186107B (enExample)
IE (1) IE53408B1 (enExample)
IL (1) IL66606A (enExample)
IT (1) IT1152505B (enExample)
LT (1) LT2436B (enExample)
LU (1) LU84347A1 (enExample)
LV (2) LV5511A3 (enExample)
NL (2) NL192739C (enExample)
NZ (1) NZ201668A (enExample)
OA (1) OA07174A (enExample)
SE (1) SE448543B (enExample)
SU (1) SU1447284A3 (enExample)
UA (1) UA5971A1 (enExample)
ZA (1) ZA826120B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
FR2531958B1 (fr) * 1982-08-17 1986-10-31 May & Baker Ltd Nouveaux derive
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
CN100366253C (zh) * 1995-09-25 2008-02-06 赛诺菲-安万特美国有限责任公司 1,2,4-苯并三嗪氧化物制剂
EP1706407A2 (en) 2003-12-30 2006-10-04 Chemagis Ltd. Novel crystalline forms of temozolomide
EP1845973B1 (en) 2005-01-21 2015-08-12 Astex Therapeutics Limited Pharmaceutical compounds
PE20080695A1 (es) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラa選択的阻害作用を有する新規アミノピリジン誘導体
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
EP2213673B1 (en) 2007-10-23 2013-06-05 Msd K.K. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (es) * 2007-12-18 2009-07-26 Pharminox Ltd AMIDAS DE ACIDO 3-SUBSTITUIDO-4-OXO-3,4-DIHIDRO-IMIDAZO[5,1-d] [1,2,3,5-TETRACINA-8-CARBOXILICO Y SU EMPLEO
EP2367828B1 (en) * 2008-11-24 2014-06-11 Reliance Life Sciences Pvt., Ltd. Process for the preparation of tetrazine derivatives
US8481503B2 (en) 2009-03-06 2013-07-09 Merck Sharp & Dohme Corp. Combination cancer therapy with an AKT inhibitor and other anticancer agents
CA2763766A1 (en) 2009-06-23 2010-12-29 Pharminox Limited 3-substituted-8-substituted-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
RU2462466C1 (ru) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Замещенные азоло[1,2,4,5]тетразины - ингибиторы актинобактериальных серин-треониновых протеинкиназ
EP2766041B1 (en) 2011-10-12 2018-12-05 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
CN120661674A (zh) 2016-03-15 2025-09-19 奥莱松基因组股份有限公司 用于治疗实体瘤的lsd1抑制剂的组合
KR101847342B1 (ko) * 2017-05-08 2018-04-11 (주)센텍코리아 웨어러블 체지방 연소량 측정기
US20240400572A1 (en) * 2021-09-23 2024-12-05 Yale University Compounds and methods for treating cancers that are mgmt deficient regardless of mmr status

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (de) * 1979-08-09 1981-02-26 Basf Ag Azolo- eckige klammer auf 5,1-d eckige klammer zu - eckige klammer auf 1,2,3,5 eckige klammer zu -tetrazin-4-one und verfahren zur herstellung dieser verbindungen

Also Published As

Publication number Publication date
FI73434C (fi) 1987-10-09
NL192739C (nl) 1998-01-06
LT2436B (lt) 1994-02-15
SE448543B (sv) 1987-03-02
FI822921A0 (fi) 1982-08-23
IL66606A0 (en) 1982-12-31
LV5621A3 (lv) 1994-05-10
CH655114A5 (fr) 1986-03-27
UA5971A1 (uk) 1994-12-29
FI73434B (fi) 1987-06-30
FR2511679A1 (fr) 1983-02-25
NL990010I1 (nl) 1999-07-01
KR890000094B1 (ko) 1989-03-07
DE3231255A1 (de) 1983-03-03
SU1447284A3 (ru) 1988-12-23
IE53408B1 (en) 1988-11-09
IT1152505B (it) 1987-01-07
DK161147C (da) 1991-11-18
AU571430B2 (en) 1988-04-21
IT8222938A0 (it) 1982-08-23
DK377882A (da) 1983-02-25
SE8204817D0 (sv) 1982-08-23
FI822921L (fi) 1983-02-25
NL8203286A (nl) 1983-03-16
LU84347A1 (fr) 1983-06-07
ES8400438A1 (es) 1983-11-01
BE894175A (fr) 1983-02-23
NZ201668A (en) 1985-08-16
ES515176A0 (es) 1983-11-01
NL990010I2 (nl) 1999-09-01
CA1197247A (fr) 1985-11-26
GB2104522B (en) 1985-06-12
DE3231255C2 (enExample) 1992-02-27
JPS5843975A (ja) 1983-03-14
IL66606A (en) 1987-07-31
DE19975037I2 (de) 2001-06-13
KR840001175A (ko) 1984-03-28
NL192739B (nl) 1997-09-01
LV5511A3 (lv) 1994-03-10
OA07174A (fr) 1984-04-30
JPH045029B2 (enExample) 1992-01-30
HU186107B (en) 1985-06-28
ATA319182A (de) 1985-09-15
FR2511679B1 (enExample) 1985-02-01
AU8749382A (en) 1983-03-03
ZA826120B (en) 1983-07-27
IE822026L (en) 1983-02-24
GEP19960641B (en) 1996-11-15
DK161147B (da) 1991-06-03
IT8222938A1 (it) 1984-02-23
GB2104522A (en) 1983-03-09
SE8204817L (sv) 1983-02-25
AT380256B (de) 1986-05-12

Similar Documents

Publication Publication Date Title
FR2500308B3 (enExample)
FR2501380B1 (enExample)
DE3138365C2 (enExample)
FR2511679B1 (enExample)
FR2499331B1 (enExample)
FR2500943B3 (enExample)
FR2500430B1 (enExample)
FR2498122B1 (enExample)
DK45782A (enExample)
FR2498802B1 (enExample)
FR2500484B1 (enExample)
FR2498211B1 (enExample)
DE3231609C2 (enExample)
FR2500710B1 (enExample)
FR2500209B1 (enExample)
FR2498392B1 (enExample)
FR2498892B3 (enExample)
FR2499641B1 (enExample)
FR2500500B1 (enExample)
FR2502358B1 (enExample)
FR2499104B1 (enExample)
FR2502332B3 (enExample)
FR2500777B1 (enExample)
JPS57172098U (enExample)
FR2502764B3 (enExample)